Cobicistat/elvitegravir/emtricitabine/tenofovir-alafenamide

Reactions Weekly ◽

10.1007/s40278-021-97207-0 ◽

2021 ◽

Vol 1859 (1) ◽

pp. 111-111

Keyword(s):

Tenofovir Alafenamide

Download Full-text

Phase 3 Randomized, Controlled Trial of Switching to Fixed-dose Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) from Boosted Protease Inhibitor-based Regimens in Virologically Suppressed Adults: Week 48 Results

10.26226/morressier.5aeaf2d35800a00019097f88 ◽

2018 ◽

Author(s):

Jürgen K. Rockstroh ◽

Christian Wisskirchen

Keyword(s):

Randomized Controlled Trial ◽

Protease Inhibitor ◽

Controlled Trial ◽

Phase 3 ◽

Randomized Controlled ◽

Tenofovir Alafenamide

Download Full-text

Human medicines European public assessment report (EPAR): Genvoya, elvitegravir / cobicistat / emtricitabine / tenofovir alafenamide, HIV Infections, Date of authorisation: 19/11/2015, Revision: 20, Status: Authorised

Case Medical Research ◽

10.31525/cmr-624f2d ◽

2019 ◽

Author(s):

Keyword(s):

Hiv Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Tenofovir Alafenamide

Download Full-text

Initiation of First-line Antiretroviral Treatment With TENOFOVIR ALAFENAMIDE - EMTRICITABINE - BICTEGRAVIR at the First Clinical Contact in France: Trial IMEA 055 - FAST

Case Medical Research ◽

10.31525/ct1-nct03858478 ◽

2019 ◽

Author(s):

Keyword(s):

Antiretroviral Treatment ◽

Tenofovir Alafenamide

Download Full-text

Quantification of Tenofovir Alafenamide Adherence (QUANTI-TAF)

Case Medical Research ◽

10.31525/ct1-nct04065347 ◽

2019 ◽

Author(s):

Keyword(s):

Tenofovir Alafenamide

Download Full-text

Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in HIV-1 Infected Marginalized Populations Who Are Virologically Suppressed

Case Medical Research ◽

10.31525/ct1-nct04132674 ◽

2019 ◽

Author(s):

Keyword(s):

Fixed Dose Combination ◽

Marginalized Populations ◽

Dose Combination ◽

Tenofovir Alafenamide ◽

Download Full-text

Bictegravir, Emtricitabine, and Tenofovir Alafenamide Fixed-Dose Combination for Treatment of HIV in Adolescents and Children: Week 48 Results from an Open-Label, Multicentre, Phase 2/3 Paediatric Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3666840 ◽

2020 ◽

Author(s):

Aditya H. Gaur ◽

Mark F. Cotton ◽

Carina A. Rodriguez ◽

Eric J. McGrath ◽

Elizabeth Hellstrom ◽

...

Keyword(s):

Fixed Dose Combination ◽

Phase 2 ◽

Multicentre Phase ◽

Paediatric Trial ◽

Dose Combination ◽

Tenofovir Alafenamide

Download Full-text

Safety and Pharmacokinetics of a Tenofovir Alafenamide Fumarate-Emtricitabine based Oral Antiretroviral Regimen for Prevention of HIV Acquisition in Women: A Randomized Controlled Trial

EClinicalMedicine ◽

10.1016/j.eclinm.2021.100893 ◽

2021 ◽

Vol 36 ◽

pp. 100893

Author(s):

Andrea R. Thurman ◽

Jill L. Schwartz ◽

Mackenzie L. Cottrell ◽

Vivian Brache ◽

Beatrice A. Chen ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Controlled Trial ◽

Randomized Controlled ◽

Tenofovir Alafenamide ◽

Hiv Acquisition ◽

Prevention Of Hiv

Download Full-text

Tenofovir Alafenamide improves proximal tubular markers in CHB patients long-term treated with Tenofovir Disoproxil Fumarate: A real-life study based on the EASL switching criteria

Digestive and Liver Disease ◽

10.1016/j.dld.2020.12.040 ◽

2021 ◽

Vol 53 ◽

pp. S14

Author(s):

A. Loglio ◽

M. Viganò ◽

M. Borghi ◽

C. Gentile ◽

F. Facchetti ◽

...

Keyword(s):

Tenofovir Disoproxil Fumarate ◽

Real Life ◽

Tubular Markers ◽

Proximal Tubular ◽

Real Life Study ◽

Tenofovir Alafenamide

Download Full-text

Outcomes associated with treatment change from tenofovir disoproxil fumarate to tenofovir alafenamide in HIV‐1‐infected patients: a real‐world study in Japan

HIV Medicine ◽

10.1111/hiv.13061 ◽

2021 ◽

Author(s):

Naoki Kanda ◽

Koh Okamoto ◽

Hisatoshi Okumura ◽

Makiko Mieno ◽

Kentaro Sakashita ◽

...

Keyword(s):

Tenofovir Disoproxil Fumarate ◽

Treatment Change ◽

Tenofovir Alafenamide ◽

Download Full-text

Human Immunodeficiency Virus Pre-Exposure Prophylaxis: Use of Emtricitabine/Tenofovir Alafenamide

The Journal for Nurse Practitioners ◽

10.1016/j.nurpra.2021.01.002 ◽

2021 ◽

Author(s):

Christopher W. Blackwell ◽

Humberto Lopez Castillo

Keyword(s):

Human Immunodeficiency Virus ◽

Immunodeficiency Virus ◽

Tenofovir Alafenamide ◽

Exposure Prophylaxis

Download Full-text